Background
DKD, diabetic, prediabetes, diabetes
PREDIABETES, DIABETES
In recent decades, the number of patients with diabetes and prediabetes has increased worldwide [To delay the onset and progression of DKD, glycemic, blood pressure, and lipid control targets are set for diabetic patients; additionally, they are provided with advice on lifestyle changes, including nutritional management and exercise, to achieve their recommended targets [SGLT2i were first approved for use in 2012 in Europe and then in the US and Japan in 2014. Several SGLT2is are already widely used not only glycemic control but also for the reduction of CV mortality [